Navigation Links
Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
Date:2/5/2009

us' new facility and Pharmaceutical Park will require an estimated additional RMB400 million (about $58.5 million). Plans call for funding the estimated additional RMB400 million through a combination of internally generated cash, low interest local bank loans collateralized by the land, government grants distributed through China's Western Region Development Policy and Technology Sponsorship Policy, the sale or rental of land use rights to the 800 mu of land which will not be used for its new facility or Pharmaceutical Park, and other financing means. Lotus recently submitted its feasibility study for development of its new facility and Pharmaceutical Park to the National Development and Reform Commission as part of its application for a government grant.

''As part of our long term plans for growth, we are pleased to have purchased the land use rights for property on which to develop a new facility and Pharmaceutical Park, and are excited by this opportunity to expand our business in Inner Mongolia,'' said Dr. Zhongyi Liu, the CEO and Chairman of Lotus. ''This important first step puts our plans for expansion during the next five years into action.''

Construction of the new facility is estimated to take three years.

Inner Mongolia Offers Cost Savings

Liang Fang's Inner Mongolia branch, established in December 2008, has a business registration certificate from Inner Mongolia's local government. Lotus' wholesale business for the distribution of drugs is now conducted through Liang Fang's Inner Mongolia branch, which anticipates that it may not have to pay any income taxes for an eight year period, and anticipates on paying income taxes at a reduced rate for the subsequent eight years.

''We expect to realize significant cost savings by expanding into Inner Mongolia. Once our new facility is completed and sales begin, we expect our new Inner Mongolia operations, like our whole
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Lotus Blossom Consulting Announces E-Book on Infertility Treatment Financing
2. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
3. Lotus Pharmaceuticals Raises $5 Million in Private Placement
4. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
5. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
6. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
7. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
8. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
9. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
10. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
11. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Hills, CA (PRWEB) September 23, 2014 ... of Diabetes and Digestive and Kidney Diseases ... leading to more cases of adults and children developing ... patients from 2005 - 2011 across several U.S. cities, ... Researchers discovered that patients usually sought treatment for kidney ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 Dr. ... on the restoration and replacement of teeth, recently ... of Restorative Dentistry and Prosthodontics (CARDP) annual Scientific ... prosthodontist at the Anacapa Dental Art Institute, on ... Esthetic Implant Supported Maxillary Prostheses” at 2:30 p.m. ...
(Date:9/23/2014)... 2014 Eight-week program, “Healing Female Pain” reaches ... other chronic pelvic or sexual pain, teaching intuitive Mind Body ... the Gallup poll, 1 in 7 women between the ages ... Many of those women suffer in silence, finding it difficult ... type of pain varies from woman to woman and can ...
(Date:9/23/2014)... New York, NY (PRWEB) September 23, 2014 ... managed IT solutions firm based in New York City, ... 7 to approximately 3,000 desktop clients located in the ... The upgrade will help modernize the bank’s corporate and ... their NY Metro branch locations, and their NY Metro ...
(Date:9/23/2014)... Irvine, CA (PRWEB) September 23, 2014 ... encourages personal growth and exploration through the presentation ... available for download in the Apple® App Store. ... to contribute compelling and informative content to the ... to gain new followers and expand audience reach, ...
Breaking Medicine News(10 mins):Health News:New Study Finds Link Between Higher Temperatures and Kidney Stones in the United States 2Health News:New Study Finds Link Between Higher Temperatures and Kidney Stones in the United States 3Health News:Woodland Hills Dental Implant Center Owner, One of Ventura’s Best Cosmetic Dentists, Returns from Prestigious Speaking Engagement to Canada’s Elite Dental Professionals 2Health News:Woodland Hills Dental Implant Center Owner, One of Ventura’s Best Cosmetic Dentists, Returns from Prestigious Speaking Engagement to Canada’s Elite Dental Professionals 3Health News:Woodland Hills Dental Implant Center Owner, One of Ventura’s Best Cosmetic Dentists, Returns from Prestigious Speaking Engagement to Canada’s Elite Dental Professionals 4Health News:Mind Body Expert Launches Pelvic Pain Relief Program 2Health News:Calling All Experts: New Mobile Learning App Accepting Content Contributors 2
... Mylan Inc. (Nasdaq: MYL ) today ... Genpharm ULC received final approvals from the U.S. ... New Drug Applications (ANDAs) for Lamotrigine Tablets. Genpharm ... for a separate Lamotrigine product, Lamotrigine Tablets Chewable ...
... Challenges Venture Industry to Step Up Investments in Healthcare ... States is on the verge of building a "new ... healthcare venture capital firm Psilos Group. But the same ... the Obama administration, the economics of healthcare will not ...
... Dr. Michael Forster of the UNT Health ... University of Southern California,s School of ... be a key to living longer. Their study ... recently published in several scientific journals and articles.The ...
... Resources, Gold Standard for Rheumatoid Arthritis in 2012, ... Mass., Jan. 28 Decision Resources, one of ... pharmaceutical and healthcare issues, finds that surveyed rheumatologists ... signs and symptoms of rheumatoid arthritis at one ...
... -Expects to File Pennsaid FDA Resubmission Within 60 ... Inc. (TSX: NRI), a Canadian drug development company ... products delivered to and through the skin using ... announced that it has successfully completed all of ...
... Jan. 28 BD (Becton, Dickinson and Company) (NYSE: ... for the first fiscal quarter ended December 31, 2008, representing ... This quarter,s growth rate reflects the unfavorable impact from ... nearly 3 percentage points. "BD is off to a ...
Cached Medicine News:Health News:Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD 2Health News:Obama Reforms Could Spark 'New Healthcare Economy' If Investors Increase Funding, Says Leading Healthcare Venture Firm 2Health News:Obama Reforms Could Spark 'New Healthcare Economy' If Investors Increase Funding, Says Leading Healthcare Venture Firm 3Health News:Obama Reforms Could Spark 'New Healthcare Economy' If Investors Increase Funding, Says Leading Healthcare Venture Firm 4Health News:UNT Health Science Center Researchers Discover Eating Less May Not Increase Life Expectancy 2Health News:UNT Health Science Center Researchers Discover Eating Less May Not Increase Life Expectancy 3Health News:Current and Emerging Therapies Have No Advantage Over Enbrel in Reducing the Signs and Symptoms of Rheumatoid Arthritis 2Health News:Current and Emerging Therapies Have No Advantage Over Enbrel in Reducing the Signs and Symptoms of Rheumatoid Arthritis 3Health News:Nuvo Research Announces Successful Completion Of All Pennsaid(R) Studies 2Health News:Nuvo Research Announces Successful Completion Of All Pennsaid(R) Studies 3Health News:Nuvo Research Announces Successful Completion Of All Pennsaid(R) Studies 4Health News:BD Announces Results for First Fiscal Quarter 2Health News:BD Announces Results for First Fiscal Quarter 3Health News:BD Announces Results for First Fiscal Quarter 4Health News:BD Announces Results for First Fiscal Quarter 5Health News:BD Announces Results for First Fiscal Quarter 6Health News:BD Announces Results for First Fiscal Quarter 7Health News:BD Announces Results for First Fiscal Quarter 8Health News:BD Announces Results for First Fiscal Quarter 9Health News:BD Announces Results for First Fiscal Quarter 10
(Date:9/23/2014)... 23, 2014   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues  ("BioLife" ... its Scientific Advisory Board.  The new members are ... PhD. Dr. Acker is a Senior Development ...
(Date:9/22/2014)... Spain , September 23, 2014 ... to meet health authorities, increasing rigor for trial master ... life sciences industry,s largest TMF survey to date reveals ... that plan to provide auditors with remote access to ... of TMF owners surveyed in the Veeva ...
(Date:9/22/2014)... The western European automated endoscope reprocessor ... a replacement market with fewer new installations due ... partnerships are redefining competitive landscape in western ... details about revenue forecasts, unit shipments, market share ... country. The changing landscape makes it important to ...
Breaking Medicine Technology:BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 3Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 4Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3
... 6, 2011 The American Animal Hospital Association ... ) are collaborating on a new series for online ... real-life examples, the "Solve It! Series" combines engaging content ... element of mystery. Designed by a panel of experts, ...
... 6, 2011 ContinuumRx and Mississippi Baptist Health Systems ... new home infusion pharmacy that will serve ... model designed to improve patient outcomes with a more ... partnership will not only improve our core operations and ...
Cached Medicine Technology:American Animal Hospital Association and Heska Corporation Announce New Online Continuing Education Series 2ContinuumRx Forms Healthcare Joint Venture with Mississippi Baptist Health Systems 2
Half pin skeletal traction pins with cove point....
Instera pins are sterile packaged and are available in 0.89, 1.1, 1.5, and 2.0mm diameters....
Knowles Pins are available in 9" (228mm) overall length with 9/64" (3.5mm) shaft diameter and 1/4" (6.4mm) square bead....
Kirschner Wires are available in four point styles ranging from .028 to .062 in. Smooth tip wire available in 4, 6 and 9 in. lengths. Threaded tip available. Material: DePuy certified stainless steel...
Medicine Products: